Valeant Pharmaceuticals International Inc (NYSE:VRX)

22.24
Delayed Data
As of May 25
 +0.02 / +0.09%
Today’s Change
10.94
Today|||52-Week Range
24.43
+7.03%
Year-to-Date
Ruane Cunniff's 5 New Buys of 1st Quarter
May 23 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close22.22
Today’s open22.16
Day’s range22.09 - 22.32
Volume3,470,573
Average volume (3 months)10,312,518
Market cap$7.3B
Data as of 4:02pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-19.38%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-9.82%
P/E ratioNM
Price/Sales0.84
Price/Book1.24

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+0.85+0.85%
CTLTCatalent Inc+0.05+0.13%
ACADACADIA Pharmaceutica...+0.22+1.26%
TAROTaro Pharmaceutical ...-0.24-0.21%
Data as of 4:02pm ET, 05/25/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)$0.76
Annual revenue (last year)$8.7B
Annual profit (last year)$2.4B
Net profit margin27.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive Vice President
Paul S. Herendeen
Corporate headquarters
Laval, Qubec

Forecasts